Co Administration of GnRH Agonist and hCG for Final Oocyte Maturation
Status:
Unknown status
Trial end date:
2018-03-01
Target enrollment:
Participant gender:
Summary
All the studies, demonstrating improved oocyte maturity and high pregnancy rate with the dual
trigger are all retrospective. The investigators therefore aim to perform a prospective
randomized controlled study in normal responders, comparing cycles triggered with hCG to
those triggered with hCG+GnRH agonist.